A double-blind, randomized, lamivudine-controlled clinical trial of DAIDING (adefovir dipivoxil) for lamivudine-resistant patients with chronic hepatitis B

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Volumn 14, Issue 11, 2006, Pages 803-805

  Wang, Yu ming ^a   Chen, Yao kai ^b   Zhang, Da zhi ^b   Lei, Bing jun ^b   Lu, Zhi meng ^b   Yin, You kuan ^b   Yu, Yun song ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ADENINE; ANTIVIRUS AGENT; DRUG DERIVATIVE; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS B; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADENINE; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; YOUNG ADULT;

EID: 77954509992     PISSN: 10073418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)